OrthoAccel currently has two full-time executives. Including service providers, consultants, contract employees, and partners, about twenty people work for OrthoAccel.
No. OrthoAccel is privately owned. Its financing to date has included individual investors and institutional venture investors. For a complete overview of the company's financing history, visit here.
The device is not currently approved for commercial use by FDA. OrthoAccel will be seeking FDA approval at the appropriate time, once its safety and effectiveness have been clearly demonstrated.
OrthoAccel aspires to improve orthodontic treatment - both by making it safer and by decreasing treatment duration - through the commercialization of innovative technologies.
